RESUMO
One of the biggest threats to human well-being and public health is antibiotic resistance. If allowed to spread unchecked, it might become a major health risk and trigger another pandemic. This proves the need to develop antibiotic resistance-related global health solutions that take into consideration microdata from various global locations. Establishing positive social norms, guiding individual and group behavioral habits that support global human health, and ultimately raising public awareness of the need for such action could all have a positive impact. Antibiotic resistance is not just a growing clinical concern but also complicates therapy, making adherence to current guidelines for managing antibiotic resistance extremely difficult. Numerous genetic components have been connected to the development of resistance; some of these components have intricate paths of transfer between microorganisms. Beyond this, the subject of antibiotic resistance is becoming increasingly significant in medical microbiology as new mechanisms underpinning its development are identified. In addition to genetic factors, behaviors such as misdiagnosis, exposure to broad-spectrum antibiotics, and delayed diagnosis contribute to the development of resistance. However, advancements in bioinformatics and DNA sequencing technology have completely transformed the diagnostic sector, enabling real-time identification of the components and causes of antibiotic resistance. This information is crucial for developing effective control and prevention strategies to counter the threat.
Assuntos
Antibacterianos , Resistência Microbiana a Medicamentos , Humanos , Resistência Microbiana a Medicamentos/genética , Antibacterianos/farmacologia , Antibacterianos/uso terapêutico , Bactérias/efeitos dos fármacos , Bactérias/genética , Farmacorresistência Bacteriana/genética , Infecções Bacterianas/tratamento farmacológico , Infecções Bacterianas/microbiologiaRESUMO
In the modern global context of interconnected populations, the recent emergence of infectious diseases involves complex interactions. The purpose of this study is to investigate the spatial correlations between urban characteristics, taking into account the socio-ecological aspects, and the emergence of infectious diseases. Using exploratory spatial data analysis and spatial regression between the infectious disease emergence data and 14 urban characteristics, we analyzed 225 spatial units in South Korea, where there was a re-emergence of measles and a 2015 outbreak of Middle East Respiratory Syndrome. As results of exploratory spatial data analysis, the emerging infectious diseases had spatial dependence and showed spatial clusters. Spatial regression models showed that urban characteristic factors had different effects according to the type of infectious disease. Common factors were characteristics related to low socioeconomic status in water or food-borne diseases and manageable infectious diseases. Intermittent infections disease epidemics are related to high-quality residential environments and the response capacity of the local government. New infectious diseases are different than other infectious diseases, which are related to the ecological environment. This study suggests spatial policies for preventing infectious diseases considering the spatial relationships between urban characteristics and infectious diseases as well as the management of public health.
RESUMO
The design, synthesis and antimicrobial evaluation of a novel series of azaspiro analogues of linezolid (1) have been described. Linezolid comprises of a morpholine ring which is known for its metabolism-related liabilities. Therefore, the key modification made in the linezolid structure was the replacement of morpholine moiety with its bioisostere, 2-oxa-6-azaspiro[3.3]heptane. Furthermore, the replacement of N-acetyl terminal of 1 with various aromatic or aliphatic functionalities was carried out. The title compounds were evaluated against a panel of Gram-positive and Gram-negative bacteria and Mycobacterium tuberculosis. Subsequent structure-activity relationship (SAR) studies identified several compounds with mixed antibacterial and antitubercular profiles. Compound 22 (IC50 0.72, 0.51, 0.88, 0.49 µg/mL for Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus, Bacillus subtilis, respectively) exhibited similar antibacterial profile as 1. The N-acetyl derivative 18 was similar to 1 in antitubercular profile. Thus, the present study successfully demonstrated the use of azaspiro substructure in the medicinal chemistry of antibacterial and antitubercular agents.